In a single-centre RCT of patients with septic shock, a 5-day neostigmine infusion added to standard therapy lowered day-5 TNF-alpha vs placebo (mean 40 vs 67 pg/mL; p=0.002). Secondary: 28-day mortality was 26% vs 54% (p=0.02).
RCT
Bashni T et al. Effect of Neostigmine on Attenuation of Proinflammatory Cytokines When Given as an Adjuvant Therapy in Septic Shock: A Randomized Control Trial